These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35820706)

  • 1. PVT1 is a stress-responsive lncRNA that drives ovarian cancer metastasis and chemoresistance.
    Tabury K; Monavarian M; Listik E; Shelton AK; Choi AS; Quintens R; Arend RC; Hempel N; Miller CR; Györrfy B; Mythreye K
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35820706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1.
    Liu E; Liu Z; Zhou Y
    Int J Clin Exp Pathol; 2015; 8(4):3803-10. PubMed ID: 26097562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway.
    Chen Y; Li F; Li D; Liu W; Zhang L
    Clin Immunol; 2021 Jun; 227():108728. PubMed ID: 33878452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA PVT1-mediated miR-543/SERPINI1 axis plays a key role in the regulatory mechanism of ovarian cancer.
    Qu C; Dai C; Guo Y; Qin R; Liu J
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32441301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of lncRNA PVT1 promotes ovarian cancer proliferation by binding to miR-140.
    Ding Y; Fang Q; Li Y; Wang Y
    Mamm Genome; 2019 Aug; 30(7-8):217-225. PubMed ID: 31222482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PVT1 functions as an oncogene in ovarian cancer via upregulating SOX2.
    Zou MF; Ling J; Wu QY; Zhang CX
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7183-7188. PubMed ID: 30468460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified LncRNA PVT1 promotes lung cancer proliferation and metastasis by facilitating VEGFC expression.
    Pan Y; Liu L; Cheng Y; Yu J; Feng Y
    Biochem Cell Biol; 2020 Dec; 98(6):676-682. PubMed ID: 33167678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY; Jian YK; Zhu HY; Li B
    Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31/ CDK1.
    Tian Z; Cao S; Li C; Xu M; Wei H; Yang H; Sun Q; Ren Q; Zhang L
    J Cell Physiol; 2019 Apr; 234(4):4799-4811. PubMed ID: 30317572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
    PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes.
    Zhou C; Yi C; Yi Y; Qin W; Yan Y; Dong X; Zhang X; Huang Y; Zhang R; Wei J; Ali DW; Michalak M; Chen XZ; Tang J
    Mol Cancer; 2020 Jul; 19(1):118. PubMed ID: 32727463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.
    Shang AQ; Wang WW; Yang YB; Gu CZ; Ji P; Chen C; Zeng BJ; Wu JL; Lu WY; Sun ZJ; Li D
    Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G222-G232. PubMed ID: 31125260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability.
    Xu Q; Lin YB; Li L; Liu J
    Biochem Biophys Res Commun; 2020 Jun; 526(4):857-864. PubMed ID: 32278547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1.
    Shen SN; Li K; Liu Y; Yang CL; He CY; Wang HR
    Mol Oncol; 2019 Dec; 13(12):2554-2573. PubMed ID: 31369196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
    Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer.
    Yang J; Li C; Mudd A; Gu X
    Biosci Biotechnol Biochem; 2017 Dec; 81(12):2301-2306. PubMed ID: 29050519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA PVT1 epigenetically stabilizes and post-transcriptionally regulates FOXM1 by acting as a microRNA sponge and thus promotes malignant behaviors of ovarian cancer cells.
    Yi K; Hou M; Yuan J; Yang L; Zeng X; Xi M; Chen J
    Am J Transl Res; 2020; 12(6):2860-2874. PubMed ID: 32655815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.